1

11

Investor PresentationLeading developer & manufacturer of sustainable packaging

March 2016For

per

sona

l use

onl

y

Disclaimer

Forward looking statements disclaimer

This presentation contains “forward-looking statements.” Such forward-looking statements may include, without limitation:(i) estimates of future earnings;(ii) estimates of future production and sales;(ii) estimates of future cash costs;(iv) estimates of future cash flows;(v) statements regarding future debt repayments; and(vi) estimates of future capital expenditures.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is expressed ingood faith and believed to have a reasonable basis. However, forward looking statements are subject to risks, uncertainties and other factors,which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements.Such risks include, but are not limited to increased production costs, as well as political and operational risks in the countries and states inwhich we operate or sell product to, and governmental regulation and judicial outcomes.

The Company does not undertake any obligation to release publicly any revisions to any “forward-looking statement” to reflect events orcircumstances after the date of this presentation, or to reflect the occurrence of unanticipated events, except as may be required underapplicable securities laws.

All financial amounts are expressed in Australian dollars unless otherwise indicated.

For

per

sona

l use

onl

y

3

• SECOS manufactures bioplastic* resinsfrom renewable resources used toproduce films and packaging products

• Uniquely positioned - a leading developerand manufacturer of sustainable andcompostable packaging solutions

• Core market segments

- Films & Packaging

- Waste Management Solutions

• Global manufacturing and distribution

• Formed through merger of CardiaBioplastics and Stellar Films in April 2015

• Experienced Board and executive team

• ASX-listed company (ASX: SES)

Capital Structure

ASX code SES

Shares on issue 124.2mil

Share price (last sale 2 March 2016) 9.0 cents

Market capitalisation $11.1 m

12 Monthly rolling turnover $1.3mil

Top 20 shareholders 61.34%

Total number of shareholders(10th March 2016)

1407

* Bioplastics: sustainable bio-based and/or biodegradable plastics

Business Overview

Corporate OverviewF

or p

erso

nal u

se o

nly

Leadership Team

4

Mr Richard TegoniExecutive Chairman

Background in Finance, Banking, Sales & Marketing. MBA (AGSM), Diploma inFinancial Markets (SIA)Appointed Executive Chairman September 2014. Appointed Non-ExecutiveDirector December 2012 and Non-Executive Chairman October 2013.

Mr Stephen WaltersGroup MD

More than 20 years experience in plastics & packaging in GeneralManagement, Commercial & Sales roles. B.Bus (Marketing)Appointed as Group Managing Director in April 2015.

Dr Frank GlatzCEO – Cardia Bioplastics

Background in FMCG in the plastics industry with an emphasis ondevelopment of new technologies & product applications. PH. D, M.Sc, MBAAppointed 1st May 2009.

Mr Trevor HainesCFO

More than 20 years experience in senior accounting & group controllingmanagement roles in various divisions of ICI Australia, AVC & Orica Australia.B.Com, FCPA. Appointed as Chief Financial Officer in April 2015.

Ms Rekha BhambhaniCompany Secretary

CFO for the Cardia Bioplastics business prior to the merger.B.Com, ACIS, ASA, ACA (ICAI)Appointed as Company Secretary in August 2010.

For

per

sona

l use

onl

y

5

Global Market Opportunity

Source: European Bioplastics/ IfBB Industry Report 2015

Global Bioplastics Growth

SECOS is strategically positioned to benefit from the trend to sustainable packaging

• Global bioplastics market is forecast to grow by >280% from 2016 to 2019

Bioplastics packaging is less than1% of the global plastics packaging market with exponentialgrowth potential, driven by:

• Increasing government regulation ofenvironment and waste management

• Increasing organic waste recycling

• Increased cost of landfills

• Increased consumer demand forsustainable products

• Global brands transitioning tobioplastics to meet social demand

For

per

sona

l use

onl

y

SECOS Product Focus

• SECOS produces an extensive range of sustainable and compostable bioplasticsmade from renewable resources:

– Resins

– Cast & blown films

– Bags

• Proprietary patent protected manufacturing processes

• Able to produce a wide range of size, thickness and colours, including printed films

• Thermal and adhesive laminates (textile back sheet) either plain or printed

Core product applications

– Compostable waste management solutionsRubbish management products, dog bags and other applications

– Sustainable bioplastic film and packaging productsUsed in food packaging, feminine hygiene products and diapers

6

For

per

sona

l use

onl

y

7

SECOS Waste Management Solutions

7

For

per

sona

l use

onl

y

8

SECOS Bioplastic Films & Packaging Products

8

For

per

sona

l use

onl

y

SECOS - Global Manufacturing Capability

SECOS has developed proprietary manufacturing processes for its

bioplastic products with:

• Manufacturing plants in Melbourne (Australia), Kuala Lumpur

(Malaysia) and Nanjing (China).

• Production of high quality cast films, bioplastic resins & finished

products derived from renewable resources.

• Annual production capacity of c. 7,200 tonnes of bioplastics

resins and c. 17,000 tonnes of film and finished products with

cost effective capacity expansion options

• 1-4 colour off line printing

• High speed bag making with several design & size options

• A fully integrated product supply from bioplastic resin to certified

compostable and Biohybrid™ films and bags that ensures

product quality and cost competiveness.

• Quality systems ISO9001 certified

9

For

per

sona

l use

onl

y

10

SECOS - Global Distribution

Resin Production Finished Goods Sales Offices Distributors

• Head Office - Melbourne, Australia

• Manufacturing – Melbourne, Australia; Kuala Lumpur, Malaysia & Nanjing, China

• Sales & Operational Offices - Australia, Malaysia, China & USA

• Global distributor network across the Americas, Europe, Asia, Middle East & Africa

For

per

sona

l use

onl

y

Achievements since Merger:• Relaunch of Stellar Australia - unique technology to produce high grade Biohybrid™ films

– Early orders of $4.8million p.a. (>100% improvement in sales H1 2015 vs H1 2014)

– Over 60% production capacity available for further growth

• Nanjing plant efficiency increased from 65% to 90% with further productivity gains planned

– Direct sales of dog bags from Nanjing, China plant to major US Pet Store Chains

• Biohybrid Film trial successes with key customers

– Early acceptance of SECOS technology a critical milestone – expected to drive ongoing sales growth

• Over 17 Australian Councils now buying Cardia waste diversion products

• Acquired 6 new key customers & several independent supermarkets across Australia

• Debtor finance facility (A$2.1m) secured

• Merger benefits being realised

– Improved manufacturing efficiencies

– Strategic focus on specialised waste management and films & packaging markets

– Customer strategy re-focused on long term relationships and higher margin segments

– Improved supplier terms and relationships

2015 in Review

11

For

per

sona

l use

onl

y

2015 in Review

12

Challenge Impact/Resolution

Major Customer delay Major global hygiene product company failed to place promised film orders in H1‒ SECOS had delayed other customer production to meet promised orders‒ orders from other customers now accepted with deliveries ramping up

Akronn Joint Venture Cash support required by JV was higher than expected by circa $500,000‒ divestment of asset in progress with modest cash recovery expected

Raw Material off-spec Raw material supplied by third party to Malaysian plant in H1 2016 was off spec‒ forced production to slow in Malaysia during H1‒ new raw material now supplied, with production returning to normal output‒ cost to Group greater than $130,000, with financial claim pending

Delay In establishingdebtor facility

Debtor finance facility delayed by additional due diligence by lender‒ created six month funding delay to budget production plans‒ facility now in place, with first draw-down made in late December 2015

Early challenges that have now been addressed:

For

per

sona

l use

onl

y

Sales Growth

• Q2 2016 Sales impacted by major multi-national customer delay, raw material issues, financingdelays, and unscheduled maintenance

• Sales reduced by strategic switch from low margin high volume sales to more profitable products

• These issues have been resolved, leading to higher confidence in sales growth outlook

• Revenue excludes Akronn joint venture which is now treated as an available for sale asset

13

$0

$1,000

$2,000

$3,000

$4,000

$5,000

$6,000

$7,000

$8,000

Q1'16 - Actual Q2'16 - Actual Q3'16 - F'cast Q4'16 - F'cast

Films & Packaging Waste Mngt Dog Bags

Quarterly Sales since Merger (April 2015)“000

For

per

sona

l use

onl

y

Marketing Highlights

Waste Management

• Secured leading market position in the supply of organic waste managementsystems with 17 Australian Councils now buying Cardia’s Bioproducts

• Cardia kitchen tidy bins & Cardia Compostable bags nominated as industrybenchmark for kitchen organics waste diversion programme.

• System implemented in 120,000 households (6% of Victorian households).

• Expanded sales of organic waste management solutions into the US and UK.

• Leading global retailers (with benchmark sustainability criteria) acceleratepurchases of Biohybrid™ & Compostable dog waste and kitchen tidy bags.

• Fully integrated business supplying resins, Compostable and Biohybrid™ films andwaste management products ensuring product quality and cost competiveness.

14

For

per

sona

l use

onl

y

Marketing Highlights

Films and PackagingAustralian Biofilm manufacturing & sales

• Scaled up production of proprietary Biohybrid™ films for the global personal care& hygiene markets

• H1 2015 sales up 100% on H1 2014

Stellar Films Malaysia

• Delivered solid sales with strong customer demand from existing and newcustomers.

• Achieved improved profitability in the December 2015 half year

Cardia Bioplastics

• Sealed Air increased its purchases of Cardia Compostable film to meet customerdemand for its new PakNatural® Biodegradable Cushion Bags.

• Secured major UK water distributor for Cardia’s Bag-in-Bag packaging films

15

For

per

sona

l use

onl

y

Financial Summary“Like for like” first half results1 (pre/post merger)

6 Months ended ($’000) 31/12/2015 31/12/2014 Variance

Sales Revenue 10,882 13,004 - 2,122

Gross Profit 746 (217) + 963

Other Income 9 73 - 64

Expenditure (2,852) (3,568) + 716

Loss from continuing operations (2,097) (3,712) + 1,615

16

Reduced sales in H1 2015 reflect:

• Reduced revenue from wholesale trading due to withdrawal from lower margin sales

• Reduction in sales to Chinese Government agencies (lower margin)

• Closure of unprofitable Brazil operations

• Sales exclude Akronn Industries (now available for sale asset)

Merger benefits now starting to emerge in terms of improved profitability – further manufacturingefficiencies and cost reductions to be achieved over second half of 2016 FY

1 Key Highlights from “like for like” comparative financial statements should be read in conjunction with the full SECOS half year report

Significant improvement in operating and trading profile:

For

per

sona

l use

onl

y

Growth Strategy

1. Expand film and resin sales via newly appointed sales agents in the Middle East,Philippines, USA & India

2. Expand compostable bag sales to governments, councils and retail from current beachheadposition with 17 councils in Australia

3. Expand dog waste bag sales in Asia and US from current sales to two of USA’s largest retailpet chains

4. Increase utilisation of Cardia’s proprietary resins by expanding international sales andincreased integration into multiple product categories

5. Continue to improve production and scale of personal hygiene films with a focus on MiddleEast, Philippines, USA & India

6. Secure trade finance and further debtor finance to support growth

7. Continue to improve manufacturing efficiencies via automation and improved utilisationrates

17

For

per

sona

l use

onl

y

Share Purchase Plan

• Share Purchase Plan (SPP) announced on 9 March 2016

• Provides Eligible Shareholders1 with the opportunity to increase their shareholding onfavourable terms at historically low prices and to participate further in SECOS’s future growth

• Eligible Shareholders can subscribe for between A$1,000 and A$15,000 of new fully paidordinary shares at 8.2 cents per share

• SPP Offer price represents a 20% discount to the volume weighted average price of SECOSshares traded over the last 5 days prior to announcement of the SPP

• Total funds raised under the SPP will be limited to A$1.0 million - preference will be given toEligible Shareholders who are still shareholders at the time of scaleback (if applicable).

• SPP being conducted to:

– support the Group’s ongoing working capital requirements, particularly in respect of theanticipated rapid growth in Cardia’s waste management solutions’ business; and

– assist in funding capital expenditure to increase production capacity

1 All persons registered as a SECOS shareholder on the Record Date (9 March 2016) with an address on the register inAustralia or New Zealand

18

For

per

sona

l use

onl

y

Investment Summary

• SECOS is focused on rapidly growing bioplastics and sustainable packaging market

• Expanding sales driven by effective marketing of unique environmentally friendly productsthat meet the global trend for sustainable products

• Strong IP and patent position on technology and comprehensive range of high performancesustainable packaging products

• Sales strategy focused on high profile brand owners, retailers, packaging companies andAustralian Councils

• Joint product development initiatives with leading consumer goods and global packagingcompanies

• Cost-effective manufacturing in Nanjing, Kuala Lumpur and Melbourne, with low costexpansion options and global distribution network

• Highly focused management team with internationally recognised industry experts insustainable packaging

19

For

per

sona

l use

onl

y